42 related articles for article (PubMed ID: 37119033)
1. Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study.
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Glimelius I; Marklund A; Larsen TS; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
Br J Haematol; 2023 Aug; 202(4):785-795. PubMed ID: 37325886
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.
Vandtved JH; Øvlisen AK; Baech J; Weinrich UM; Severinsen MT; Maksten EF; Jakobsen LH; Glimelius I; Kamper P; Hutchings M; Specht L; Dahl-Sørensen R; Christensen JH; El-Galaly TC
Br J Haematol; 2024 Apr; ():. PubMed ID: 38685596
[TBL] [Abstract][Full Text] [Related]
3. Short Communication: CD4 Count and HIV RNA Trends for HIV-Associated Lymphoproliferative Disorders in Malawi.
Kaimila B; van der Gronde T; Kasonkanji E; Fox P; Chikasema M; Tewete B; Gopal S
AIDS Res Hum Retroviruses; 2017 Oct; 33(10):1045-1047. PubMed ID: 28548539
[TBL] [Abstract][Full Text] [Related]
4. Men treated with BEACOPP for Hodgkin lymphoma may be at increased risk of testosterone deficiency.
Micas Pedersen S; Feltoft CL; Nielsen TH; de Nully Brown P; Gang AO; Pedersen LM; Jørgensen N
Ann Hematol; 2024 Jan; 103(1):227-239. PubMed ID: 37870576
[TBL] [Abstract][Full Text] [Related]
5. Hodgkin disease-an ever-evolving therapy.
Dann EJ
Rambam Maimonides Med J; 2014 Oct; 5(4):e0029. PubMed ID: 25386345
[TBL] [Abstract][Full Text] [Related]
6. Intensive care in children with non-Hodgkin lymphoma in Sweden.
Ranta S; Broman LM; Mellgren K; Norén-Nyström U; Svahn JE; Törnudd L; Heyman M; Harila A
Acta Paediatr; 2024 May; ():. PubMed ID: 38703016
[No Abstract] [Full Text] [Related]
7. Histo-blood group antigen profile of Australian Aboriginal children and seropositivity following oral rotavirus vaccination.
Middleton BF; Danchin M; Cunliffe NA; Jones MA; Boniface K; Kirkwood CD; Gallagher S; Kirkham LA; Granland C; McNeal M; Donato C; Bogdanovic-Sakran N; Handley A; Bines JE; Snelling TL
Vaccine; 2023 Jun; 41(24):3579-3583. PubMed ID: 37179162
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the efficiency of ABVD versus BEACOPP for Hodgkin lymphoma treatment: a meta-analysis.
Jiang Y; Chen Y; Huang R; Chen G
Int J Hematol; 2016 Oct; 104(4):413-9. PubMed ID: 27531149
[TBL] [Abstract][Full Text] [Related]
9. Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study.
Entrop JP; Weibull CE; Smedby KE; Jakobsen LH; Øvlisen AK; Molin D; Glimelius I; Marklund A; Holte H; Fosså A; Smeland KB; El-Galaly TC; Eloranta S
Int J Cancer; 2023 Aug; 153(4):723-731. PubMed ID: 37119033
[TBL] [Abstract][Full Text] [Related]
10. Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
Gillessen S; Plütschow A; Fuchs M; Markova J; Greil R; Topp MS; Meissner J; Zijlstra JM; Eichenauer DA; Bröckelmann PJ; Diehl V; Borchmann P; Engert A; von Tresckow B
Lancet Haematol; 2021 Apr; 8(4):e278-e288. PubMed ID: 33770483
[TBL] [Abstract][Full Text] [Related]
11. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey.
Boltežar L; Pintarić K; Jezeršek Novaković B
J Assist Reprod Genet; 2016 Mar; 33(3):325-333. PubMed ID: 26678493
[TBL] [Abstract][Full Text] [Related]
12. ABVD and BEACOPP regimens' effects on fertility in young males with Hodgkin lymphoma.
Amin MSA; Brunckhorst O; Scott C; Wrench D; Gleeson M; Kazmi M; Ahmed K
Clin Transl Oncol; 2021 Jun; 23(6):1067-1077. PubMed ID: 32944834
[TBL] [Abstract][Full Text] [Related]
13. Long-term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.
André MPE; Carde P; Viviani S; Bellei M; Fortpied C; Hutchings M; Gianni AM; Brice P; Casasnovas O; Gobbi PG; Zinzani PL; Dupuis J; Iannitto E; Rambaldi A; Brière J; Clément-Filliatre L; Heczko M; Valagussa P; Douxfils J; Depaus J; Federico M; Mounier N
Cancer Med; 2020 Sep; 9(18):6565-6575. PubMed ID: 32710498
[TBL] [Abstract][Full Text] [Related]
14. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Federico M; Luminari S; Iannitto E; Polimeno G; Marcheselli L; Montanini A; La Sala A; Merli F; Stelitano C; Pozzi S; Scalone R; Di Renzo N; Musto P; Baldini L; Cervetti G; Angrilli F; Mazza P; Brugiatelli M; Gobbi PG;
J Clin Oncol; 2009 Feb; 27(5):805-11. PubMed ID: 19124807
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
